These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24700598)

  • 61. Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem.
    Zhang T; Cheng H; Li Y; Dong YZ; Zhang Y; Cheng XL; Wang AM; Dong YL
    J Clin Pharm Ther; 2019 Jun; 44(3):440-446. PubMed ID: 30737860
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
    Clemmons AB; Bech CF; Pantin J; Ahmad I
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):820-826. PubMed ID: 29292056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
    Huang M; Wu H; Zhou J; Xu M; Zhou S
    Arch Iran Med; 2018 Aug; 21(8):349-355. PubMed ID: 30113856
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study.
    Kane-Gill SL; Ostermann M; Shi J; Joyce EL; Kellum JA
    Drug Saf; 2019 Oct; 42(10):1149-1155. PubMed ID: 31240688
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients.
    Brumer E; Dubrovskaya Y; Scipione MR; Aberle C; Rahimian J; Papadopoulos J
    J Pharm Pract; 2015 Dec; 28(6):511-7. PubMed ID: 25112304
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
    Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Performance of a vancomycin dosage regimen developed for obese patients.
    Reynolds DC; Waite LH; Alexander DP; DeRyke CA
    Am J Health Syst Pharm; 2012 Jun; 69(11):944-50. PubMed ID: 22610026
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
    Kim T; Kandiah S; Patel M; Rab S; Wong J; Xue W; Easley K; Anderson AM
    BMC Res Notes; 2015 Oct; 8():579. PubMed ID: 26476979
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nephrotoxicity comparison of two commercially available generic vancomycin products.
    Sutton JD; Mynatt RP; Kaye KS; Murray KP; Rybak MJ; Pogue JM
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5470-4. PubMed ID: 26124161
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pre-Treatment Serum C-Reactive Protein Level Is An Independent Risk Factor for Development of Nephrotoxicity in Patients Receiving High-Dose Vancomycin.
    He J; Mao EQ; Jing F; Jiang HT; Yang WH; Chen EZ
    Pharmacology; 2016; 97(5-6):294-300. PubMed ID: 26919511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
    Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin.
    Rutter WC; Hall RG; Burgess DS
    Am J Health Syst Pharm; 2019 Aug; 76(16):1211-1217. PubMed ID: 31369116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between colistin dose and development of nephrotoxicity.
    Lee YJ; Wi YM; Kwon YJ; Kim SR; Chang SH; Cho S
    Crit Care Med; 2015 Jun; 43(6):1187-93. PubMed ID: 25756417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.
    Prabaker KK; Tran TP; Pratummas T; Goetz MB; Graber CJ
    J Hosp Med; 2012 Feb; 7(2):91-7. PubMed ID: 22086511
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
    Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
    PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
    Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
    Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.